Ex Parte NEERVEN - Page 9

                 Appeal 2007-1070                                                                                      
                 Application 09/467,901                                                                                

                                                   DISCUSSION                                                          
                 Obviousness of claims 1-5, 8-14, 16, and 21-23                                                        
                        Claims 1-5, 8-14, 16, and 21-23 stand rejected under 35 U.S.C. § 103                           
                 as obvious over Johansen in view of Johnson and Frank (Answer 3).                                     
                        A claimed invention is obvious “if the differences between the subject                         
                 matter sought to be patented and the prior art are such that the subject matter                       
                 as a whole would have been obvious at the time the invention was made to a                            
                 person having ordinary skill in the art to which said subject matter pertains.”                       
                 35 U.S.C. § 103(a).  To make this determination, we consider in the context                           
                 of the knowledge and level of skill possessed by a person of ordinary skill in                        
                 the art whether such a person would have had reason to combine the prior art                          
                 in the fashion claimed by the application at issue.  See KSR Int’l Co. v.                             
                 Teleflex Inc., 550 U.S. __, 82 USPQ2d 1385, 1396 (2007).                                              
                        In this case, we find that the Examiner has presented sufficient                               
                 evidence that a person of ordinary skill in the art would have had adequate                           
                 reason at the time the application was filed to have utilized Frank’s FcεR                            
                 molecule in Johansen’s method of detecting specific IgE antibodies.  Frank                            
                 explicitly states that its FcεR molecule is an improvement over anti-IgE                              
                 antibody (i.e., the anti-IgE antibody utilized in Johansen’s method) “because                         
                 the use of canine FcεR avoids complications presented by the use of . . . anti-                       
                 IgE (i.e., anti-IgE antibodies),” such as non-specific binding (Frank, col. 2,                        
                 ll. 19-21; FF 12-13).  Frank recognizes that this property is advantageous in                         
                 IgE antibody-based detection (e.g., diagnostic, screening) methods and kits                           
                 (Frank, col. 2, ll. 14-17; FF 11).  The skilled worker would recognize this as                        



                                                          9                                                            

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next

Last modified: September 9, 2013